X

Health Care

Earnings preview: Veeva Systems likely to continue the momentum in Q2

Veeva Systems Inc. (NYSE: VEEV) is set to release its second-quarter earnings on Tuesday, August 27 after the market closes.…

Immunogen Inc (NASDAQ: IMGN) Q2 2019 Earnings Call Transcript

Immunogen Inc (IMGN) Q2 2019 earnings call dated Aug 02, 2019 Corporate Participants: Courtney O'Konek -- Senior Director of Corporate Communications and Investor…

Exelixis surpasses Q2 earnings estimate by 6 cents

Exelixis Inc. (NASDAQ: EXEL) reported second-quarter earnings of 29 cents per share, down 6.4% year-over-year. The bottom line surpassed the…

Vertex Pharmaceuticals Q2 profit jumps 29%, beats estimates

Vertex Pharmaceuticals Incorporated (NASDAQ: VRTX) reported a 29% jump in earnings for the second quarter of 2019 helped by strong…

ACADIA Pharmaceuticals Q2 results beat estimates, raises outlook

ACADIA Pharmaceuticals (NASDAQ: ACAD) stock soared 5% in the after-market trading hours as the biopharma firm reported better-than-expected Q2 results.…

Amarin’s stock gains on Q2 results beat

Amarin Corporation plc (NASDAQ: AMRN) reported better-than-expected revenue and earnings for the second quarter of 2019, allowing the stock to…

BioTelemetry Q2 earnings exceed estimates on record revenues; stock up 10%

Medical technology company BioTelemetry, Inc. (NASDAQ: BEAT) reported higher earnings and revenues for the June quarter. Earnings topped expectations, while…

Gilead’s Q2 results beat estimates

Gilead Sciences Inc. (NYSE: GILD) beat market estimates for revenue and earnings in the second quarter of 2019. Shares were…

Amgen beats Q2 earnings and revenue estimates

Amgen Inc. (NASDAQ: AMGN) reported second quarter 2019 adjusted EPS of $3.97 on revenue of $5.9 billion. Analysts had predicted…

Pfizer’s stock suffers as Q2 results and Mylan deal fail to impress Wall Street

Pfizer Inc.’s (NYSE: PFE) shares continue to trade in red after the company narrowly missed revenue estimates for the second…

Celgene Q2 profit beats estimates, lifts FY19 guidance

Celgene Corporation (NASDAQ: CELG) reported a 50% jump in earnings for the second quarter of 2019 helped by higher revenue…

Merck rises on oncology strength post Q2 earnings

Shares of pharmaceutical giant Merck (NYSE: MRK) rose 3% before the market hours on Tuesday after the company reported second-quarter…

Eli Lilly Q2 profit beats estimates, lifts FY19 forecast

Eli Lilly and Company (NYSE: LLY) swung to a profit in the second quarter of 2019 from a loss last…

Illumina’s Q2 results beat market estimates

Illumina Inc. (NASDAQ: ILMN) beat analysts’ forecasts for revenue and earnings in the second quarter of 2019. Despite the beat,…

Earnings preview: What to look for when Gilead reports Q2 results

Gilead Sciences Inc. (NYSE: GILD) is scheduled to report second quarter 2019 earnings results on Tuesday, July 30, after market…

Sanofi slips to a loss in Q2 on Eloctate impairment charge

Sanofi (NASDAQ: SNY) slipped to a loss in the second quarter of 2019 from a profit last year, due to…

Earnings preview: A look at key factors affecting Pfizer’s Q2 results

Pfizer Inc. (NYSE: PFE) is scheduled to report second quarter 2019 earnings results on Tuesday, July 30, before market open.…

AbbVie tops Q2 views; lifts FY19 earnings outlook

AbbVie's (NYSE: ABBV) earnings and revenue for the second quarter of 2019 surpassed Wall Street's estimates. AbbVie reported adjusted EPS…

Bristol-Myers Q2 earnings, revenue top Street; stock dips on weak guidance

Biopharma company Bristol-Myers Squibb (NYSE: BMY) on Thursday reported higher earnings and revenues for the second quarter, The results also…

AstraZeneca’s Q2 results beat market expectations

AstraZeneca Plc (NYSE: AZN) topped market estimates for revenue and earnings in the second quarter of 2019, giving shares a…

What to expect from AbbVie Q2 earnings

AbbVie (NYSE: ABBV) is scheduled to report its earnings results for the second quarter of 2019 on Friday before the…